Cera Sanitaryware Limited held its Board of Directors meeting on August 7, 2026, which commenced at 11:30 AM and concluded at 12:05 PM. The Board approved the unaudited financial results for the quarter ended June 30, 2026, which were reviewed by the Audit Committee on the same date.

Financial Performance (All figures in ₹ lakhs)

Income Statement:

  • Revenue from Operations: ₹48,598.16 (Q1 FY2027) vs ₹40,680.61 (Q1 FY2026)
  • Other Income: ₹2,128.72 (Q1 FY2027) vs ₹1,860.04 (Q1 FY2026)
  • Total Income: ₹50,726.88 (Q1 FY2027) vs ₹42,540.65 (Q1 FY2026)

Expenses Breakdown:

  • Cost of Materials Consumed: ₹8,305.28
  • Purchases of Stock-in-Trade: ₹17,658.68
  • Changes in Inventories: ₹356.23
  • Employee Benefits Expense: ₹7,837.05
  • Finance Costs: ₹126.84
  • Depreciation and Amortization: ₹942.25
  • Other Expenses: ₹9,519.25
  • Total Expenses: ₹44,745.58

Profitability:

  • Profit Before Exceptional Items and Tax: ₹5,981.30
  • Exceptional Items: Nil (₹10.65 crore reversal in Q4 FY2026 disclosed)
  • Profit Before Tax: ₹5,981.30
  • Tax Expense: ₹1,450.26 (Current Tax: ₹1,092.23, Deferred Tax: ₹358.03)
  • Net Profit for Period: ₹4,531.04
  • Other Comprehensive Income: ₹8.23
  • Total Comprehensive Income: ₹4,539.27

Per Share Data:

  • Basic EPS: ₹35.13
  • Diluted EPS: ₹35.13
  • Paid-up Equity Share Capital: ₹644.88 lakhs (Face Value ₹5 per share)

Comparative Performance

Quarterly Comparison (Q1 FY2027 vs Q1 FY2026):

  • Revenue increased 19.5% from ₹40,680.61 lakhs to ₹48,598.16 lakhs
  • Net Profit decreased 2.6% from ₹4,653.40 lakhs to ₹4,531.04 lakhs

Previous Quarter (Q4 FY2026) Reference:

  • Q4 FY2026 Revenue: ₹62,399.64 lakhs (Audited)
  • Q4 FY2026 Net Profit: ₹7,733.59 lakhs (Audited)

Exceptional Items Explanation

The company disclosed details about exceptional items related to the implementation of New Labour Codes effective from November 21, 2025. During Q3 FY2026, the company had recognized a provision of ₹1,845.97 lakhs for incremental liabilities towards past service cost relating to gratuity and leave benefits. Based on subsequent reassessment after government clarifications and actuarial valuation, the company reversed excess provision of ₹1,065.29 lakhs during Q4 FY2026, reducing the final liability to ₹780.68 lakhs as of March 31, 2026.

Corporate Actions

  • The ESOP Trust transferred 2,011 equity shares (face value ₹5 each) upon exercise of stock options under ESOS 2024
  • The Board recommended a dividend of ₹75 per fully paid-up equity share for FY2025-26 at its meeting on May 8, 2026
  • Shareholders approved the dividend in the Annual General Meeting held on July 23, 2026